So, for these patients, if there are indications for a diabetes or weight loss medication, it may make sense to prescribe a GLP-1 receptor agonist. Advertisement Advertisement The drug does not provide lasting disease control for most patients A review of pathophysiology, risk factors, clinical presentation and treatment options Registry data highlight visual gains in patients with legal blindness Its the first step toward reliable screening with your smartphone Fixational eye movement is similar in left and right eyes of people with normal vision Oral medication may have potential to preserve vision and shrink tumors prior to surgery or radiation A new online calculator can determine probability of melanoma Only 33% of patients have long-term improvement after treatment
XI, Comprehensive Biochemistry, Vol 46
Recent research suggests GLP-1 therapy may help
Semaglutide and tirzepatide have FDA-approved uses under certain brand names and indications
Kind Patches, a popular brand on TikTok, has renamed its GLP-1 patches as berberine patches, though the formula remains the same, according to its website
doi: 10.1001/jama.2016.7602 21 Uptodate
